Pepticom Raises $5 Million in Series A Funding
Pepticom's unique artificial intelligence (AI) technology streamlines and significantly accelerates the ability of researchers to discover advanced peptide-based drug candidates. Peptides are used in various therapies, and are recognized for being highly selective and efficacious as well as relatively safe.
Healx Ltd raises $56m in Series B financing
AI-driven drug repurposing company Healx Ltd (Cambridge, UK) raises US$56m in a Series B financing and launches global accelerator programme for orphan diseases. The financing was led by Atomico and joined by Intel Capital, Global Brain and btov Partners as new
Varian buys software developer for AI cancer work
Varian said it is investing in privately held Oncora Medical and will partner with the software company to develop machine learning-guided decision support tools. The aim is to help doctors create personalized treatment plans for cancer patients. Financial terms weren't
FDA clears GE’s AI-powered x-ray algorithms for triaging collapsed lungs
GE Healthcare has received 510(k) clearance for AI algorithms designed to detect a type of collapsed lung on x-ray images. The FDA clearance covers a set of algorithms that GE has embedded in its Optima XR240amx mobile x-ray device, thereby
Atomwise Announces Largest China-US Collaboration for AI Drug Discovery
Atomwise, the leader in artificial intelligence (AI) for drug discovery, today announced a collaboration with Hansoh Pharmaceutical Group Company Limited (“Hansoh Pharma”), a leading biopharmaceutical company in China, to design and discover potential drug candidates for up to eleven undisclosed